CUHK_CCT00063
2005-09-12
Retrospective
N/A
Roche
Benny Fok
bfok@cuhk.edu.hk
Brian Tomlinson
btomlinson@cuhk.edu.hk
A placebo controlled, randomized study to examine the impact of 24-week orlistat treatment on postprandial triglyceridaemia, steatohepatitis and cardiovascular risk factors in overweight Chinese patients
Yes
2003-11-04
Obesity
Drug
Orlistat
24 weeks
Placebo
Chinese patients with obesity and dyslipidaemia
Randomized
Placebo
Double-blind
Parallel
2004-01-01
40
Not Yet Recruiting
Postprandial triglyceridaemia, visceral and hepatic fat deposition
Body weight, cardiovascular risk profiles
2009-11-27
Yes
None
|
|
|
|
|
---|---|---|---|---|
No documents yet. |